ArticleMovement disorders : official journal of the Movement Disorder Society2025

The FDA Has Ended Required Blood Monitoring for Clozapine Use-Will This Impact the Management of Parkinson's Disease Psychosis?

Daniel Weintraub et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.